Phentermine Hydrochloride
- Product NDC
- 68071-3535
- Requested package NDC
- 68071-3535-3
- 11-digit product format
- 680713535
- Labeler code
- 68071
- Product ID
- 68071-3535_2d3fa192-bcd3-7d2f-e063-6394a90aa73f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Phentermine Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA040886
- Marketing category
- ANDA
- Marketing start
- 2012-08-07
- Substance
- PHENTERMINE HYDROCHLORIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040886-001 | PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | 30MG | CAPSULE / ORAL | AA | 2008-03-31 | |
| A040886-002 | PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | 15MG | CAPSULE / ORAL | AA | 2008-03-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040886-001 | AA |
| A040886-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040886-001 | PHENTERMINE HYDROCHLORIDE | 30MG | CAPSULE / ORAL | AA | 2008-03-31 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040886-002 | PHENTERMINE HYDROCHLORIDE | 15MG | CAPSULE / ORAL | AA | 2008-03-31 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040886-001 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040886-002 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Calvin Scott & Co., Inc. | 2f3b738f-d66b-40c1-8e69-bcd50bce3e47 | 2026-05-21 | Warnings, Adverse reactions | 040886 ANDA040886 |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 4000c00f-aa6c-4ea5-af0e-149dde3c74db | 2025-10-20 | Warnings, Adverse reactions | 040886 ANDA040886 |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | f115ad6d-cf62-40e7-89d1-6183a9b5071f | 2025-10-17 | Warnings, Adverse reactions | 040886 ANDA040886 |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2abc445c-daa8-7326-e054-00144ff88e88 | 2025-10-15 | Warnings, Adverse reactions | 040886 ANDA040886 |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | A-S Medication Solutions | 5234cabd-6b3e-404d-a0cd-256ee5fcc8f1 | 2025-10-08 | Warnings, Adverse reactions | 040886 ANDA040886 |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Martek Pharmacal Co. | 1fe86035-19ef-4944-ad81-c0167a8e7fec | 2025-07-23 | Warnings, Adverse reactions | 040886 ANDA040886 |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Martek Pharmacal Co. | 1a8b3c4a-f7fe-5cc9-e063-6394a90a90dd | 2025-07-21 | Warnings, Adverse reactions | 040886 ANDA040886 |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 0b4d847a-fcda-df31-e063-6294a90a0c5e | 2025-02-03 | Warnings, Adverse reactions | 040886 ANDA040886 68071-3535-3 68071-3535 68071353503 |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Bryant Ranch Prepack | 7f1c3a5d-dd9b-4441-a483-aa5777f8e40c | 2024-05-29 | Warnings, Adverse reactions | 040886 ANDA040886 |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | KVK-Tech, Inc. | b963f7bb-fa65-4e28-81c9-282fbe70a6a6 | 2024-04-18 | Warnings, Adverse reactions | 040886 ANDA040886 |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Proficient Rx LP | 3a3259ec-ded3-427f-843d-928d130de3da | 2020-03-01 | Adverse reactions | 040886 ANDA040886 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Phentermine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PHENTERMINE HYDROCHLORIDE | 30 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0K2I505OTV | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 900038 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0b4d847a-fcda-df31-e063-6294a90a0c5e | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3d272a3f-17c0-421d-bc43-3cbdb719258d | Product name | 1 | 20250303 |
| 32c2b0bd-1f13-4890-99e0-dcd2ea16e1ab | Product name | 2 | 20230717 |
| ebeae3eb-385d-62da-8827-5ffa80b14e90 | Product name | 2 | 20170810 |
| 1d682039-1122-1cb7-f3f4-c0a028b98748 | Product name | 4 | 20170124 |
| 8ef9ca65-1a6c-7225-351d-36066d0f8e56 | Product name | 3 | 20161229 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3535-3 | Phentermine Hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-3535 | PHENTERMINE HYDROCHLORIDE CAPSULE [NUCARE PHARMACEUTICALS,INC.] | 2 | Current NDC, 1 package rows | 20250205_0b4d847a-fcda-df31-e063-6294a90a0c5e.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 900038 | phentermine HCl 30 MG Oral Capsule | PSN | 0b4d847a-fcda-df31-e063-6294a90a0c5e | 2 |
| 900038 | phentermine hydrochloride 30 MG Oral Capsule | SCD | 0b4d847a-fcda-df31-e063-6294a90a0c5e | 2 |
| 900038 | phentermine hydrochloride 30 MG (equivalent to phentermine 24 MG) Oral Capsule | SY | 0b4d847a-fcda-df31-e063-6294a90a0c5e | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68071-3535-3 | 68071353503 | 30 CAPSULE in 1 BOTTLE (68071-3535-3) | 30 capsule | 2023-11-29 | No | No | Current |